GDUFA Research Outcomes
Data & AI
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to data analytics and artificial intelligence (AI) for generic product development and assessment, including the development of natural language processing (NLP) and machine learning (ML) tools
-
The Future of AI and the Generic Drug Community
Lionberger, Robert
-
Leveraging Generative AI (GenAI) to Support Regulatory Assessment
Hu, Meng
-
Generative AI-Powered Regulatory Efficiency and Excellence
Lee, Jae
-
Predicting Future Generic Drug Competition: Powering Strategic Planning Using Quantitative Methods and Modeling
Zhao, Liang
-
Big Data Application in Life Sciences
Zhao, Liang
-
FDA Scientific Efforts on Investigating Excipient-Drug Interactions
Zhang, Lei
-
Regulatory Science Issues in the Effect of Microbimes on Bioequivalence Determination for Generic Drug Products
Zhang, Lei
-
Developing a Statistical Approach to Facilitate Sameness Assessment of Complex Heterogenous Active Pharmaceutical Ingredients
Weng, Yu Ting; Hu, Meng; Zhao, Liang; Wang, Chao; Shen, Meiyu; Gong, Xiajing
-
Leveraging Large Language Models (LLMs) to Support Regulatory Assessments
Wang, Jing
-
Approaches to Analyzing Comparative Use Human Factors Studies
Wang, Jing